Results 231 to 240 of about 9,317,521 (244)

Peyronie’s disease: pharmacological treatments and limitations

Expert Review of Clinical Pharmacology, 2021
Introduction: Peyronie’s disease (PD) is a disorder of the tunica albuginea from disordered and excessive deposition of collagen resulting in a palpable scar, pain, erect penile deformity and erectile dysfunction that significantly impacts patients both ...
E. Li, Robert Esterquest, Minh N. Pham, Evan J Panken, C. Amarasekera, A. Siebert, P. Bajic, L. Levine   +7 more
semanticscholar   +1 more source

The role of imaging in the diagnosis and management of Peyronie's disease.

Current Opinion in Urology, 2020
PURPOSE OF REVIEW Several imaging modalities exist for the assessment of Peyronie's disease. However, comprehensive recommendations for using these objective modalities based on large-scale evidence-based studies do not yet exist.
M. Parmar, J. Masterson, T. Masterson
semanticscholar   +1 more source

Outcomes of a Novel Penile Traction Device in Men with Peyronie's Disease: A Randomized, Single-Blind, Controlled Trial.

Journal of Urology, 2019
PURPOSE Current penile traction therapy devices have significant limitations, including the need to use them for 3 to 8 hours per day. Given these issues, the novel RestoreX® penile traction therapy device was developed in cooperation with Mayo Clinic.
M. Ziegelmann, J. Savage, A. Toussi, M. Alom, David Yang, T. Kohler, L. Trost   +6 more
semanticscholar   +1 more source

Intralesional Collagenase Clostridium histolyticum Causes Meaningful Improvement in Men with Peyronie's Disease: Results of a Multi-Institutional Analysis

Journal of Urology, 2019
Purpose: In a multi-institutional setting we studied the efficacy and safety outcomes at multiple high volume centers where collagenase Clostridium histolyticum is used to treat Peyronie's disease.
W. Hellstrom, Hoang Minh Tue Nguyen, L. Alzweri, A. Chung, R. Virasoro, A. Tapscott, M. Ziegelmann, L. Trost, M. Gelbard   +8 more
semanticscholar   +1 more source

Mental Disorders in Peyronie's Disease: A Swedish Cohort Study of 3.5 Million Men.

Journal of Urology, 2020
PURPOSE Studies have shown that men with Peyronie's disease often suffer from psychological problems, but the psychiatric burden of this disorder remains largely unknown. We assessed risks of a range of psychiatric outcomes in a population-based, Swedish
R. Kuja-Halkola, L. Henningsohn, B. D’Onofrio, J. Mills, A. Adolfsson, H. Larsson, M. Cederlöf   +6 more
semanticscholar   +1 more source

Penile traction therapy with the new device ‘Penimaster PRO’ is effective and safe in the stable phase of Peyronie's disease: a controlled multicentre study

BJU International, 2018
To evaluate the efficacy and safety of a new penile traction device (PTD), ‘Penimaster PRO’, in a group of patients with stable Peyronie's disease (PD) compared with a non‐intervention group in a multicentre study.
I. Moncada, P. Krishnappa, J. Romero, J. Torremadé, A. Fraile, J. Martínez-Salamanca, H. Porst, L. Levine   +7 more
semanticscholar   +1 more source

Is social media reliable as a source of information on Peyronie’s disease treatment?

International journal of impotence research, 2021
N. Baydilli, I. Selvi
semanticscholar   +1 more source

Mechanical characterization of fibrotic and mineralized tissue in Peyronie’s disease

International journal of impotence research, 2021
L. Brady, C. Stender, Yak-Nam Wang, G. Schade, A. Maxwell, H. Wessells, W. Ledoux   +6 more
semanticscholar   +1 more source

Nonsurgical management of Peyronie’s disease

Nature reviews. Urology, 2018
P. Tsambarlis, L. Levine
semanticscholar   +1 more source

The Etiology of Peyronie's Disease: Pathogenesis and Genetic Contributions.

Sexual Medicine Reviews, 2020
K. L. Sharma, M. Alom, L. Trost
semanticscholar   +1 more source